Actinomycin D
CAS Number
50-76-0Synonym
dilactone actinomycin D acid, ACT, actinomycin A IV
Occurrence/Use
Medicine (antineoplastic)
Cancer Potency Information
Latest Criteria: | Proposition 65 NSRLs/MADLs |
---|---|
Inhalation Unit Risk (μg/cubic meter)-1: | 2.5 E+0 |
Inhalation Slope Factor (mg/kg-day)-1: | 8.7 E+3 |
Oral Slope Factor (mg/kg-day)-1: | 8.7 E+3 |
Comments/References: |
OEHHA 1992. Expedited Cancer Potency Values and Proposed Regulatory Levels for Certain Proposition 65 Carcinogens.
|
Proposition 65
Chemical Status
Cancer: | Currently listed |
---|---|
Reproductive Toxicity : | Currently listed |
Cancer
Listed as causing : | Listed as causing: Cancer |
---|---|
Date of Listing: |
Reproductive Toxicity
Listed as causing: | Developmental Toxicity | Developmental Toxicity |
---|---|
Date of Listing: | |
Basis for Listing : | Formally Required |
Safe Harbor Levels
Cancer | |
Last NSRL/MADL Revision: | 1992 |
---|
Documents, Presentations, and Publications
Cancer: |
|
---|
Comments
Basis for listing actinomycin D as known to the State to cause cancer changed from Labor Code to 'Formally Required to Be Labeled or Identified' effective February 22, 2013.